The tumor spectrum in the Lynch syndrome
- PMID: 16136385
- DOI: 10.1007/s10689-004-7994-z
The tumor spectrum in the Lynch syndrome
Abstract
Colorectal and endometrial cancer are the characteristic tumors of the Lynch syndrome. We reviewed the available evidence on the occurrence of other types of cancer in the syndrome, aiming to identify those types that can be included in the tumor spectrum, based on this evidence. We chose to define the tumor spectrum as comprising the cancers for which Lynch syndrome patients are at elevated risk. We found sufficiently strong and consistent evidence to include gastric cancer, small bowel cancer, hepatobiliary tract cancer, upper urologic tract cancer, ovarian cancer, and brain tumors in this spectrum, in addition to colorectal and endometrial cancer. We predict that the spectrum will expand as additional studies are reported, especially as prospective studies of mutation carriers are completed.
Similar articles
-
[Colorectal Carcinoma with Suspected Lynch Syndrome: A Multidisciplinary Algorithm].Zentralbl Chir. 2015 Dec;140(6):591-9. doi: 10.1055/s-0034-1368480. Epub 2014 Nov 5. Zentralbl Chir. 2015. PMID: 25372301 Review. German.
-
Upper urinary tract urothelial cell carcinomas and other urological malignancies involved in the hereditary nonpolyposis colorectal cancer (lynch syndrome) tumor spectrum.Eur Urol. 2008 Dec;54(6):1226-36. doi: 10.1016/j.eururo.2008.08.008. Epub 2008 Aug 12. Eur Urol. 2008. PMID: 18715695 Review.
-
Lynch syndrome and MYH-associated polyposis: review and testing strategy.J Clin Gastroenterol. 2011 Jul;45(6):488-500. doi: 10.1097/MCG.0b013e318206489c. J Clin Gastroenterol. 2011. PMID: 21325953 Review.
-
Management of extracolonic tumours in patients with Lynch syndrome.Lancet Oncol. 2009 Apr;10(4):400-8. doi: 10.1016/S1470-2045(09)70041-5. Lancet Oncol. 2009. PMID: 19341971 Review.
-
Clinicopathological comparison of colorectal and endometrial carcinomas in patients with Lynch-like syndrome versus patients with Lynch syndrome.Hum Pathol. 2015 Nov;46(11):1616-25. doi: 10.1016/j.humpath.2015.06.022. Epub 2015 Jul 8. Hum Pathol. 2015. PMID: 26319271
Cited by
-
Predictive genetic testing of first degree relatives of mutation carriers is a cost-effective strategy in preventing hereditary non-polyposis colorectal cancer in Singapore.Fam Cancer. 2012 Jun;11(2):279-89. doi: 10.1007/s10689-012-9513-y. Fam Cancer. 2012. PMID: 22350504
-
MSH2-deficient prostate tumours have a distinct immune response and clinical outcome compared to MSH2-deficient colorectal or endometrial cancer.Prostate Cancer Prostatic Dis. 2021 Dec;24(4):1167-1180. doi: 10.1038/s41391-021-00379-4. Epub 2021 Jun 9. Prostate Cancer Prostatic Dis. 2021. PMID: 34108644
-
Frequency of extracolonic tumors in Brazilian families with Lynch syndrome: analysis of a hereditary colorectal cancer institutional registry.Fam Cancer. 2010 Dec;9(4):563-70. doi: 10.1007/s10689-010-9373-2. Fam Cancer. 2010. PMID: 20697958
-
Genomic Characterization of Upper-Tract Urothelial Carcinoma in Patients With Lynch Syndrome.JCO Precis Oncol. 2018;2018:PO.17.00143. doi: 10.1200/PO.17.00143. JCO Precis Oncol. 2018. PMID: 30854504 Free PMC article.
-
Current Knowledge on Genomic Profiling of Upper Tract Urothelial Carcinoma.Genes (Basel). 2021 Feb 25;12(3):333. doi: 10.3390/genes12030333. Genes (Basel). 2021. PMID: 33668859 Free PMC article. Review.
References
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources